 The purpose of this study is to investigate whether the addition of oral maintenance chemotherapy with O-TIE Etoposide, Idarubicin, Trofosfamide for 6 months improves the event free survival EFS in patients with localised high-risk RMS and RMS-like Soft Tissue Sarcoma. 